Meeting
2013 ASCO Annual Meeting
Efficacy and safety of radiotherapy (RT) plus temozolomide (TMZ) in elderly patients (EP) with glioblastoma (GBM).
Authors
Giuseppe Lombardi
Medical Oncology 1, Veneto Institute of Oncology-IRCCS, Padova, Italy
Giuseppe Lombardi , Luisa Bellu , Franco Berti , Patrizia Farina , Sara Galuppo , Fable Zustovich , Alessandro Della Puppa , Carla Carollo , Roberta Bertorelle , Domenico D'Avella , Vittorina Zagonel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 31, 2013 (suppl; abstr 2043)
DOI
10.1200/jco.2013.31.15_suppl.2043
Abstract #
2043
Poster Bd #
1G
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma.
First Author: Jiayi Huang
Poster
2011 ASCO Annual Meeting
TEMOBIC: A ANOCEF phase II study of BCNU and temozolomide (TMZ) combination prior to radiotherapy (RT) in anaplasic oligodendroglial gliomas (AOG).
First Author: O. L. Chinot
Poster
2020 ASCO Virtual Scientific Program
Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM).
First Author: Shiao-Pei S. Weathers
Poster
2019 ASCO Annual Meeting
Stratified monotherapy approach according to MGMT methylation status in elderly patients with glioblastoma.
First Author: Mitsuaki Shirahata